The differential diagnosis includes immunoblastic DLBCL and other lymphoid neoplasms with plasmacytic features such as ALK-positive DLBCL, primary effusion lymphoma (PEL), BL with plasmacytoid differentiation and plasmablastic plasmacytoma/myeloma (Table 3). The gene discussed is ALK; the disease is diffuse large B-cell lymphoma.